Ep Biocomposites Ltd Stock Price Today (NSE: EPBIO)
Fundamental Score
Ep Biocomposites Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Ep Biocomposites Ltd share price today is ₹84.00, down 18.44% on NSE/BSE as of 30 March 2026. Ep Biocomposites Ltd (EPBIO) is a Small-cap company in the Waste Management sector with a market capitalisation of ₹17.78 (Cr). The 52-week high for EPBIO share price is ₹149.90 and the 52-week low is ₹88.00. At a P/E ratio of 19.33x, EPBIO is currently trading below its industry average P/E of 20.29x. The company has a Return on Equity (ROE) of 10.22% and a debt-to-equity ratio of 0.35.
Ep Biocomposites Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Ep Biocomposites Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Ep Biocomposites Share Price: A Conservative Value Investor's Perspective
The waste management industry, particularly in its innovative corners like biocomposites, presents a unique investment landscape. Unlike traditional waste disposal, companies focused on recycling and repurposing waste streams offer the potential for circular economy models, adding layers of complexity to financial analysis. This assessment focuses on the Ep Biocomposites share price and its fundamental underpinnings from a capital safety perspective, part of a larger 80-parameter fundamental audit verified by Sweta Mishra.
At a current price of ₹98.0 and a PE ratio of 19.33, Ep Biocomposites Ltd appears to be trading at a potentially modest premium to its earnings. However, a deeper look is warranted. Compared to its peers, particularly
HI GREEN CARBON LI, a crucial factor for long-term value lies in the quality of management and its ability to execute on strategic initiatives. Are management's decisions consistently aligned with shareholder value, or are there potential risks related to capital allocation or related party transactions? These qualitative aspects, while hard to quantify, are crucial for a conservative investor.The company's Return on Capital Employed (ROCE) of 14.28% is a key metric. A consistent ROCE above the cost of capital (which needs to be determined) indicates that Ep Biocomposites Ltd is generating value from its investments. This can contribute to a stronger moat, allowing the company to reinvest earnings at attractive rates and potentially fend off competitors. However, sustainability is key. Can this ROCE be maintained or improved over the long term given the competitive landscape and potential disruptions in the biocomposites industry?
Further investigation is required to assess the debt levels, cash flow generation, and the overall financial health of Ep Biocomposites Ltd. While the current metrics offer a starting point, a thorough review of the company's financials, including a stress test of various scenarios, is essential for a conservative value investor seeking capital safety. It is important to monitor how the company's performance evolves over time in comparison to its peers, such as Vvip Infratech Ltd and Z TECH INDIA PRI.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. It is based on publicly available information and the author's interpretation. Individual investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Ep Biocomposites Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of EPBIO across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Consistent Growth Track Record (83.96% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (102.84% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Balanced Promoter Holding (70.05%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Profit Decline Concern (-57.14%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-7.50%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (0.41% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-7.51 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Ep Biocomposites Ltd Financial Statements
Comprehensive financial data for Ep Biocomposites Ltd including income statement, balance sheet and cash flow
About EPBIO (Ep Biocomposites Ltd)
EP Biocomposites Ltd is at the forefront of revolutionizing waste management through innovative and sustainable solutions. The company specializes in the development and deployment... of advanced bio-digester toilets, offering a hygienic and environmentally conscious alternative to traditional sanitation methods. These systems effectively break down organic waste, significantly reducing environmental impact and promoting cleaner and healthier communities. Complementing this, their range of sewage and effluent treatment plants leverage cutting-edge technologies to purify wastewater, enabling its safe reuse and minimizing pollution of vital water resources. EP Biocomposites is committed to transforming the landscape of waste management, fostering a circular economy, and ensuring a cleaner, more sustainable future for all. Beyond waste treatment infrastructure, EP Biocomposites Ltd. utilizes the strength and versatility of fiber-reinforced polymer (FRP) in a range of applications that support responsible waste handling. Their durable FRP dustbins are designed to withstand harsh conditions, promoting efficient waste collection in public spaces. The company's FRP roof tiles and decorative elements, crafted from sustainable materials, offer aesthetic appeal and contribute to eco-friendly construction practices. By integrating sustainable materials and designs into everyday products, EP Biocomposites promotes a holistic approach to waste reduction and resource conservation. EP Biocomposites Ltd.’s unwavering commitment to innovation extends beyond its core product lines. They are dedicated to continuous research and development, exploring new ways to harness the power of biocomposites in waste management and related fields. By fostering collaboration with researchers and industry partners, they stay at the cutting edge of sustainable technology, constantly refining their solutions and expanding their portfolio to meet the evolving needs of a world increasingly focused on environmental responsibility. Their dedication positions them as a key player in shaping the future of waste management.
Company Details
Key Leadership
EPBIO Share Price: Frequently Asked Questions
What is the current share price of Ep Biocomposites Ltd (EPBIO)?
As of 30 Mar 2026, 12:04 pm IST, Ep Biocomposites Ltd share price is ₹84.00. The EPBIO stock has a market capitalisation of ₹17.78 (Cr) on NSE/BSE.
Is EPBIO share price Overvalued or Undervalued?
EPBIO share price is currently trading at a P/E ratio of 19.33x, compared to the industry average of 20.29x. Based on this relative valuation, the Ep Biocomposites Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of EPBIO share price?
The 52-week high of EPBIO share price is ₹149.90 and the 52-week low is ₹88.00. These values are updated daily from NSE/BSE price data.
What factors affect the Ep Biocomposites Ltd share price?
Key factors influencing EPBIO share price include quarterly earnings growth (Sales Growth: -7.50%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Ep Biocomposites Ltd a good stock for long-term investment?
Ep Biocomposites Ltd shows a 5-year Profit Growth of 102.84% and an ROE of 10.22%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.35 before investing in EPBIO shares.
How does Ep Biocomposites Ltd compare with its industry peers?
Ep Biocomposites Ltd competes with major peers in the Waste Management. Investors should compare EPBIO share price P/E of 19.33x and ROE of 10.22% against the industry averages to determine competitive standing.
What is the P/E ratio of EPBIO and what does it mean?
EPBIO share price has a P/E ratio of 19.33x compared to the industry average of 20.29x. Investors pay ₹19 for every ₹1 of annual earnings.
How is EPBIO performing according to Bull Run's analysis?
EPBIO has a Bull Run fundamental score of 43.7/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does EPBIO belong to?
EPBIO operates in the Waste Management industry. This classification helps understand the competitive landscape and sector-specific trends affecting Ep Biocomposites Ltd share price.
What is Return on Equity (ROE) and why is it important for EPBIO?
EPBIO has an ROE of 10.22%, which shows decent profitability but room for improvement. ROE measures how efficiently Ep Biocomposites Ltd generates profits from shareholders capital.
How is EPBIO debt-to-equity ratio and what does it indicate?
EPBIO has a debt-to-equity ratio of 0.35, which indicates moderate leverage that should be monitored.
What is EPBIO dividend yield and is it a good dividend stock?
EPBIO offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Ep Biocomposites Ltd shares.
How has EPBIO share price grown over the past 5 years?
EPBIO has achieved 5-year growth rates of: Sales Growth 83.96%, Profit Growth 102.84%, and EPS Growth 0.41%.
What is the promoter holding in EPBIO and why does it matter?
Promoters hold 70.05% of EPBIO shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Ep Biocomposites Ltd.
What is EPBIO market capitalisation category?
EPBIO has a market capitalisation of ₹18 crores, placing it in the Small-cap category.
How volatile is EPBIO stock?
EPBIO has a beta of N/A. A beta > 1 suggests the Ep Biocomposites Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is EPBIO operating profit margin trend?
EPBIO has a 5-year average Operating Profit Margin (OPM) of 14.48%, indicating the company's operational efficiency.
How is EPBIO quarterly performance?
Recent quarterly performance shows Ep Biocomposites Ltd YoY Sales Growth of -7.50% and YoY Profit Growth of -57.14%.
What is the institutional holding pattern in EPBIO?
EPBIO has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Ep Biocomposites Ltd stock.